Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taradon Laboratories is a biotechnology company specializing in the development of bioactive proteins and bio-replenishment therapies. Founded by Dr. A.S. Naidu, the company is recognized for its pioneering research into lactoferrin and its proprietary Activated Lactoferrin (ALF) technology, which improves the protein's stability and functional efficacy. Their commercial portfolio includes products such as Lactoferrin Gold 1.8 and OsteoDenx, which target immune modulation and bone health respectively. Taradon operates with a focus on evidence-based nutraceuticals and functional food ingredients, bridging the gap between natural compounds and clinical science. The company's research extends into gastrointestinal health and systemic inflammation management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taradon Laboratories.